A controversial advertising campaign for Eucerin’s Hyaluron-Filler Epigenetic Serum has been prohibited by the Advertising Standards Authority (ASA) due to misleading assertions about its efficacy. The £49 serum’s billboard, which claimed users could appear “up to five years younger,” has raised eyebrows and prompted scrutiny over its scientific backing.
The Controversial Claim
The ASA’s ruling stems from a complaint filed in November 2025, following the advertisement’s display at Balham tube station in London. The advertisement’s claim was based on a study involving 160 participants who were asked to self-report their perceived age reduction after a four-week trial of the product. However, the ASA expressed significant concerns regarding the study’s methodology, particularly noting the absence of a control group and the subjective nature of the participants’ responses.
Beiersdorf, the parent company of Eucerin, defended the claim, stating that “up to” five years younger accurately represented the maximum potential outcome rather than a common experience among users. The company emphasised that its products are grounded in scientific research.
Methodological Flaws
The ASA’s report highlighted several methodological weaknesses in the study that underpinned the advertisement. Among these were the lack of a control group, which is crucial for establishing a product’s effectiveness, and the fact that the climate in which the serum was tested differed significantly from that of the UK, casting doubt on its applicability to local consumers.
Furthermore, Beiersdorf submitted three additional pieces of evidence to support its claims; however, all were unpublished research and did little to bolster its case. A peer-reviewed study cited by the company, although credible, did not specifically examine the serum in question.
Industry Implications
This ruling is part of a larger trend within the cosmetics industry, where misleading beauty claims have come under increasing scrutiny. Lianne Sykes, an aesthetics marketing expert, emphasised the necessity for companies to conduct extensive skin analyses over time to validate any claims made. “Consumers must interrogate the validity of these claims rather than being swayed by attractive branding and reputable names,” Sykes advised.
She also urged consumers to consider the diversity of skin biology, which means that effective skincare often results from a combination of good habits rather than relying solely on one product.
Why it Matters
The ASA’s decision to ban the Eucerin advertisement highlights the need for transparency and accountability in cosmetic marketing. As consumers become more discerning and informed, brands are compelled to uphold high standards of evidence for their claims. This case serves as a reminder that while the allure of beauty products can be compelling, it is essential to approach such claims with a critical eye, ensuring that promises of youthful skin are backed by robust scientific validation.
